Immediate Management of Diabetic Ketoacidosis (DKA)
Begin aggressive fluid resuscitation with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour for the first hour, followed by continuous intravenous regular insulin at 0.1 units/kg/hour without an initial bolus, while simultaneously monitoring and replacing potassium to prevent life-threatening hypokalemia. 1, 2
Initial Assessment and Laboratory Evaluation
Obtain the following immediately upon presentation:
- Plasma glucose, serum ketones, electrolytes with calculated anion gap, arterial blood gases (ABG), and venous pH 1, 2
- Blood urea nitrogen/creatinine, osmolality, complete blood count, electrocardiogram 1, 2
- Urinalysis and urine ketones 1, 2
- If infection suspected: bacterial cultures of blood, urine, and throat; chest X-ray if clinically indicated 1
Diagnostic criteria confirming DKA: plasma glucose >250 mg/dL, arterial pH <7.30, serum bicarbonate <18 mEq/L, and positive serum/urine ketones 2
Fluid Resuscitation Protocol
Hour 1: Administer isotonic saline (0.9% NaCl) at 15-20 mL/kg/hour to restore intravascular volume and renal perfusion 1, 2, 3
Subsequent hours: Continue fluid replacement to correct estimated deficits within 24 hours, targeting total fluid replacement of approximately 1.5-2 times the 24-hour maintenance requirements 1, 2
A critical nuance: While isotonic saline remains the standard, recent research suggests balanced crystalloid solutions may achieve faster DKA resolution, though guidelines have not yet incorporated this change 4
Insulin Therapy
Start continuous IV regular insulin infusion at 0.1 units/kg/hour WITHOUT an initial bolus 2, 3
- Goal: reduce plasma glucose by 50-75 mg/dL per hour 2
- If glucose does not fall by 50 mg/dL in the first hour, double the insulin infusion rate hourly until steady decline achieved 2
- Critical: Continue insulin infusion until DKA resolves, regardless of glucose levels 3
- When glucose reaches 200 mg/dL, add dextrose to IV fluids while maintaining insulin infusion to clear ketones 2
The 2025 guidelines from the American Diabetes Association now recommend starting insulin without a bolus, which differs from older protocols that used 0.1 units/kg bolus 2. British guidelines suggest adding subcutaneous glargine alongside IV insulin for faster resolution, though this is not yet standard in U.S. practice 4.
Electrolyte Management: Potassium is Critical
Potassium replacement must begin early to prevent life-threatening hypokalemia:
- Once renal function is confirmed and serum potassium <5.3 mEq/L, add 20-30 mEq/L potassium to IV fluids 1, 2
- Monitor serum potassium closely every 2-4 hours, as insulin therapy drives potassium intracellularly 1, 2
- Common pitfall: Failure to replace potassium adequately is a leading cause of cardiac arrhythmias and death in DKA 2
Also monitor and replace phosphate and magnesium as needed, though these are less immediately critical 4
Monitoring During Treatment
Blood glucose: Check every 1-2 hours 2
Laboratory panel (electrolytes, glucose, BUN, creatinine, osmolality, venous pH): Draw every 2-4 hours 1, 2, 3
Follow venous pH and anion gap to monitor resolution of acidosis, targeting venous pH >7.3 and anion gap ≤12 mEq/L 2
Bicarbonate: Generally NOT Recommended
Do not administer bicarbonate routinely, as it provides no benefit in resolution of acidosis and increases risks of hypokalemia, worsening ketosis, and cerebral edema 5, 4
Exception: Consider IV bicarbonate only if pH <6.9 or when pH <7.2 with serum bicarbonate <10 mEq/L in the peri-intubation period to prevent hemodynamic collapse 4
Identifying and Treating Precipitating Causes
Simultaneously address underlying triggers:
- Infections (most common): administer appropriate antibiotics 1, 6
- Myocardial infarction, stroke, sepsis 5, 2
- Insulin omission or nonadherence 6
- SGLT2 inhibitors: Discontinue 3-4 days before surgery; monitor for euglycemic DKA (can occur with normal glucose) 2, 6
Transition to Subcutaneous Insulin: Timing is Everything
DKA resolution criteria (all must be met):
Critical transition protocol:
- Administer basal insulin (glargine or detemir) 2-4 hours BEFORE stopping IV insulin 5, 1, 2
- Once patient can eat, start multiple-dose insulin schedule combining rapid-acting and long-acting insulin 1, 3
Most common error leading to DKA recurrence: Stopping IV insulin without prior basal insulin administration 1. This creates an insulin-free interval that allows ketogenesis to restart.
Special Considerations for Critically Ill Patients
Airway management: If respiratory failure is impending, proceed directly to intubation and mechanical ventilation; do NOT use BiPAP due to aspiration risk 4
Nutrition: Allow oral intake when patient is able to eat; keeping patients NPO is not standard practice and may prolong hospital stay 3, 4
Thromboprophylaxis: DKA creates a hypercoagulable state; initiate enoxaparin per standard hospital protocols after initial fluid resuscitation 3
Comorbidities requiring modified approach: pregnancy, renal disease, congestive heart failure, acute coronary syndrome, and older age all necessitate adjusted fluid rates and closer monitoring 7
Prevention of Cerebral Edema
Though rare, cerebral edema is the most feared complication, particularly in younger patients: